- Roche's Tecentriq approved as first immunotherapy drug for breast cancer – MedCity News
- FDA OKs First Immunotherapy Combo Regimen for Breast Cancer – Pharmacy Times
- FDA OKs First Immunotherapy Combo Regimen for Breast Cancer – Pharmacy Times
- Roche wins first US approval of immunotherapy for breast cancer – STAT
